Search by Drug Name or NDC

    NDC 73475-3041-05 VYVGART 20 mg/mL Details

    VYVGART 20 mg/mL

    VYVGART is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by argenx US. The primary component is EFGARTIGIMOD ALFA.

    Product Information

    NDC 73475-3041
    Product ID 73475-3041_eda70bcd-00e6-4196-9826-00ef3cd2b26b
    Associated GPIs 99398225302020
    GCN Sequence Number 082930
    GCN Sequence Number Description efgartigimod alfa-fcab VIAL 400MG/20ML INTRAVEN
    HIC3 Z29
    HIC3 Description NEONATAL FC RECEPTOR (FCRN) INHIBITORS
    GCN 51724
    HICL Sequence Number 047735
    HICL Sequence Number Description EFGARTIGIMOD ALFA-FCAB
    Brand/Generic Brand
    Proprietary Name VYVGART
    Proprietary Name Suffix n/a
    Non-Proprietary Name EFGARTIGIMOD ALFA
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 20
    Active Ingredient Units mg/mL
    Substance Name EFGARTIGIMOD ALFA
    Labeler Name argenx US
    Pharmaceutical Class Neonatal Fc Receptor Blocker [EPC], Neonatal Fc Receptor Blockers [MoA]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761195
    Listing Certified Through 2024-12-31

    Package

    NDC 73475-3041-05 (73475304105)

    NDC Package Code 73475-3041-5
    Billing NDC 73475304105
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (73475-3041-5) / 20 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2021-12-17
    NDC Exclude Flag N
    Pricing Information N/A